Wouter K. De Jong

Utrecht, UT, NL 
Utrecht, UT, NL 

Overview

Wouter De Jong practices practicing medicine in Utrecht, Netherlands.

Their clinical expertise encompasses Diphtheria and Lung Cancer.

They are actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 2 clinical trials.

Locations

Utrecht, UT, Netherlands
Other Locations
Isala Klinieken
Zwolle, OV, Netherlands
Ede, GE, Netherlands
Rotterdam, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

NVALT 28/ PRL01 Durvalumab and Low-dose Prophylactic Cranial Irradiation (PCI) Versus Durvalumab and Observation in Radically Treated Patients With Stage III Non-small Cell Lung Cancer: A Phase III Randomized Study
NVALT 28/ PRL01 Durvalumab and Low-dose Prophylactic Cranial Irradiation (PCI) Versus Durvalumab and Observation in Radically Treated Patients With Stage III Non-small Cell Lung Cancer: A Phase III Randomized Study
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2025
Intervention Type: Drug, Radiation
Study Drug: Durvalumab
Study Phase: Phase 3
Chemotherapy in KRAS Mutated Chemotherapy Naive Non-small Cell Lung Cancer Patients: a Phase III Study Comparing Cisplatin-pemetrexed With Carboplatin-paclitaxel-bevacizumab: NVALT 22
Chemotherapy in KRAS Mutated Chemotherapy Naive Non-small Cell Lung Cancer Patients: a Phase III Study Comparing Cisplatin-pemetrexed With Carboplatin-paclitaxel-bevacizumab: NVALT 22
Enrollment Status: Unknown
Publish Date: December 21, 2021
Intervention Type: Drug
Study Drugs: Carboplatin, Paclitaxel, Bevacizumab, Pemetrexed, Cisplatin
Study Phase: Phase 3
View 1 Less Clinical Trial

24 Total Publications

Advance care planning in the last year of life of patients with advanced cancer: patients' perspectives on decision-making and their family and physicians' awareness of future care preferences.
Advance care planning in the last year of life of patients with advanced cancer: patients' perspectives on decision-making and their family and physicians' awareness of future care preferences.
Journal: Journal of cancer survivorship : research and practice
Published: February 20, 2026

Frequently Asked Questions about Wouter K. De Jong

Is Wouter K. De Jong a top-rated expert for Diphtheria?

MediFind is an objective health platform that identifies experts based on real-world data. Wouter K. De Jong is classified as an Experienced expert for Diphtheria, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wouter K. De Jong participate in research or clinical trials?

Yes. Wouter K. De Jong has published 24 articles and abstracts on conditions like Diphtheria. You can view a list of Wouter K. De Jong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find De Jong's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile